Brief: ABL Diagnostics To Acquire Advanced Biological Laboratories Fedialis
Aug 31 (Reuters) - ABL Diagnostics SA ABLD.PA :
* BOARD APPROVES ACQUISITION BY ABSORPTION OF ADVANCED
BIOLOGICAL
LABORATORIES FEDIALIS SAS
* THE NEW SHARES RESULTING FROM THE MERGER WILL BE LISTED ON
EURONEXT PARIS FROM SEPTEMBER 2, 2022
Source text for Eikon: ID:nBw71gr3Ka
Further company coverage: ABLD.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on AbL Diagnostics SA
See all newsBrief: Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million
Brief: ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US
Brief: ABL Diagnostics - Changes Name To ABL Texcell Diagnostics
Brief: ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen
Brief: ABL Diagnostics Delays Half-Yearly Accounts To 30 June 2023